Latazanavir en es it fr

Latazanavir Brand names, Latazanavir Analogs

Latazanavir Brand Names Mixture

  • No information avaliable

Latazanavir Chemical_Formula


Latazanavir RX_link

Latazanavir fda sheet

Latazanavir FDA

Latazanavir msds (material safety sheet)

Latazanavir Synthesis Reference

No information avaliable

Latazanavir Molecular Weight

704.856 g/mol

Latazanavir Melting Point

No information avaliable

Latazanavir H2O Solubility

Free base slightly soluble (4-5 mg/mL)

Latazanavir State


Latazanavir LogP


Latazanavir Dosage Forms

Capsule (100 mg, 150 mg, or 200 mg)

Latazanavir Indication

For use, in combination with other antiretroviral agents, in the treatment of HIV-1 infection.

Latazanavir Pharmacology

Atazanavir (ATV) is an azapeptide HIV-1 protease inhibitor (PI). It is a protease inhibitor with activity against Human Immunodeficiency Virus Type 1 (HIV-1). Protease inhibitors block the part of HIV called protease. HIV-1 protease is an enzyme required for the proteolytic cleavage of the viral polyprotein precursors into the individual functional proteins found in infectious HIV-1. Atazanavir binds to the protease active site and inhibits the activity of the enzyme. This inhibition prevents cleavage of the viral polyproteins resulting in the formation of immature non-infectious viral particles. Protease inhibitors are almost always used in combination with at least two other anti-HIV drugs.

Latazanavir Absorption

Atazanavir is rapidly absorbed with a Tmax of approximately 2.5 hours. Administration of atazanavir with food enhances bioavailability and reduces pharmacokinetic variability

Latazanavir side effects and Toxicity

No information avaliable

Latazanavir Patient Information

Latazanavir Organisms Affected

Human immunodeficiency virus